1.71
0.00 (0.00%)
0.00 (0.00%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Pro
Monthly Subscription
for only
|
|
DDE w/Realtime (Monthly)
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Proteostasis Therapeutics Inc | PTI | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Low Price | High Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| 0.06 | 3.64% | 1.71 | 1.63 | 1.75 | 1.66 | 1.65 | 23:59:38 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 1.70 | 1.72 | 0.02 | 1.16% | 3 | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 2,200 | 758,510 | $ 1.71 | $ 1,295,972 | 1,838,830 | 0.61 - 5.26 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:24:45 | formt | 100 | $ 1.71 | USD |
Proteostasis Therapeutics Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| $ 87.43M | 51.13M | $ -61.83M | -1.60 | - | 50.58M |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | 1.10% |
Proteostasis Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical PTI Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.70 | 1.75 | 1.53 | 1.65 | 840,831 | 0.01 | 0.59% |
| 1 Month | 1.97 | 2.07 | 1.53 | 1.78 | 1,207,169 | -0.26 | -13.2% |
| 3 Months | 1.59 | 5.26 | 1.20 | 2.40 | 6,123,828 | 0.12 | 7.55% |
| 6 Months | 0.61 | 5.26 | 0.61 | 2.22 | 3,135,412 | 1.10 | 180.33% |
| 1 Year | 3.93 | 5.26 | 0.61 | 2.01 | 2,305,801 | -2.22 | -56.49% |
| 3 Years | 14.91 | 16.67 | 0.61 | 3.94 | 1,438,203 | -13.20 | -88.53% |
| 5 Years | 8.00 | 20.63 | 0.61 | 4.17 | 1,108,806 | -6.29 | -78.63% |
Proteostasis Therapeutics Description
| Proteostasis Therapeutics Inc is a United States-based company engaged in the biotechnology industry. Its core operations comprise of discovery and development of therapeutics that treat diseases caused by an imbalance in protein biosynthesis process in the body. It has developed the Disease Relevant Translation (DRT) technology platform, a drug screening approach for identifying highly translatable therapeutics. Using this platform, it has identified a new class of small molecules and amplifiers that modulate proteins in the proteostasis network. The products under its development cycle include PTI-428, which is a lead amplifier of CFTR protein. It also focuses on developing PTI-NC-733, PTI-130, Usp14 program and unfolded protein response (UPR) program. |
